Postprandial glycine as a biomarker of satiety: A dose-rising randomised control trial of whey protein in overweight women

• Published in: Appetite Vol. 169; p. 105871
• Main Authors: Lim, Jia Jiet, Sequeira, Ivana R., Yip, Wilson C.Y., Lu, Louise W., Barnett, Daniel, Cameron-Smith, David, Poppitt, Sally D.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.02.2022
• Subjects: Amino acids; Appetite; Appetite biomarkers; Biomarkers; Blood Glucose - metabolism; Cross-Over Studies; Energy Intake - physiology; Female; Glucoregulatory peptides; Glycine; Gut peptides; High protein; Humans; Insulin; Overweight; Plasma glucose; Postprandial Period; Whey Proteins; Amino acids; High protein; Glucoregulatory peptides; Appetite biomarkers; Plasma glucose; Gut peptides
• ISSN: 0195-6663; 1095-8304
• DOI: 10.1016/j.appet.2021.105871

This study aimed to identify biomarkers of appetite response, modelled using a dose-rising whey protein preload intervention. Female participants (n = 24) with body mass index (BMI) between 23 and 40 kg/m2 consumed preload beverages (0 g protein water control, WC; 12.5 g low-dose protein, LP; or 50.0 g high-dose protein, HP) after an overnight fast, in a randomised cross over design. Repeated venous blood samples were collected to measure plasma biomarkers of appetite response, including glucose, glucoregulatory peptides, gut peptides, and amino acids (AAs). Appetite was assessed using Visual Analogue Scales (VAS) and ad libitum energy intake (EI). Dose-rising protein beverage significantly changed the postprandial trajectory of almost all biomarkers (treatment*time, p < 0.05), but did not suppress postprandial appetite (treatment*time, p > 0.05) or EI (ANOVA, p = 0.799). Circulating glycine had the strongest association with appetite response. Higher area under the curve (AUC0-240) glycine was associated with lower EI (p = 0.026, trend). Furthermore, circulating glycine was associated with decreased Hunger in all treatment groups, whereas the associations of glucose, alanine and amylin with appetite were dependent on treatment groups. Multivariate models, incorporating multiple biomarkers, improved the estimation of appetite response (marginal R2, range: 0.13–0.43). In conclusion, whilst glycine, both alone and within a multivariate model, can estimate appetite response to both water and whey protein beverage consumption, a large proportion of variance in appetite response remains unexplained. Most biomarkers, when assessed in isolation, are poor predictors of appetite response, and likely of utility only in combination with VAS and EI.